Substituted triazines for malaria treatment and chemoprophylaxis

US9334246B2 · kind B2 · utility

Assignee

• The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · US

Inventors

• Richard J. Sciotti · Saline, US
• Gregory A. Reichard · Lovettsville, US
• Kristina M. Pannone · Columbia, US
• Victor E. Zottig · Bethesda, US

Key dates

• Filing date: Mar 13, 2014
• Grant date: May 10, 2016
• Expiry date: Mar 13, 2034

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed herein are triazine compounds and methods of making and using thereof to treat malaria, provide chemoprophylaxis, and/or treat or inhibit infection by one or more Plasmodium spp.